カテゴリ： Allied Market Research, 世界, 医療/バイオ

自閉症スペクトラム障害のグローバル市場（2020～2030）：自閉症、アスペルガー症候群、広汎性発達障害（PDD）、その他

■ 英語タイトル：Autism Spectrum Disorders Market By Disease (Autistic Disorder, Asperger Syndrome, Pervasive development disorder (PDD), Other), By Service (Behavioural Approaches, Early Intervention, Medication, Other Services), By Location (Hospitals, Education Counsellor Center, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23JN081）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23JN081
■ 発行日：2022年9月
■ 調査対象地域：グローバル
■ 産業分野：生命科学
■ ページ数：300
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[自閉症スペクトラム障害のグローバル市場（2020～2030）：自閉症、アスペルガー症候群、広汎性発達障害（PDD）、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本レポートでは、2021年に27,272.7百万ドルであった世界の自閉症スペクトラム障害市場規模が2031年には43,166.16百万ドルに達し、2022年から2031年にかけて年平均4.6％成長すると予測しています。Allied Market Research社の本レポートでは、世界の自閉症スペクトラム障害市場について幅広く調査し、イントロダクション、エグゼクティブサマリー、市場概要、疾患別分析（自閉症、アスペルガー症候群、広汎性発達障害（PDD）、その他）、サービス別分析（行動介入、早期介入、投薬、その他）、場所別分析（病院、教育相談センター、その他）、地域別分析（北米、ヨーロッパ、アジア太平洋、中南米/中東・アフリカ）、企業状況、企業情報など、以下の内容を掲載しています。さらに、Abbvie Inc、Axial therapeutics、Bristol Myers Squibb Co.、Cognoa Inc、Curemark LLC、dfusion inc.、EarliTec Diagnostics Inc、Jazz Pharmaceuticals、Johnson & Johnson、Novartis AGなどの企業情報が含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の自閉症スペクトラム障害市場規模：疾患別分析
- 自閉症の市場規模
- アスペルガー症候群の市場規模
- 広汎性発達障害（PDD）の市場規模
- その他疾患の市場規模
・世界の自閉症スペクトラム障害市場規模：サービス別分析
- 行動介入サービスの市場規模
- 早期介入サービスの市場規模
- 投薬サービスの市場規模
- その他サービスの市場規模
・世界の自閉症スペクトラム障害市場規模：場所別分析
- 病院における市場規模
- 教育相談センターにおける市場規模
- その他場所における市場規模
・世界の自閉症スペクトラム障害市場規模：地域別分析
- 北米の自閉症スペクトラム障害市場規模
- ヨーロッパの自閉症スペクトラム障害市場規模
- アジア太平洋の自閉症スペクトラム障害市場規模
- 中南米/中東・アフリカの自閉症スペクトラム障害市場規模
・企業状況
・企業情報

世界の自閉症スペクトラム障害市場は、2021年には272億7,270万ドルと評価され、2022年から2031年まで年平均成長率4.6%で成長して2031年には431億6,616万ドルに達すると予測されています。
自閉スペクトラム症（ASD）として知られる高度な神経疾患の一群は、幅広い行動パターンと社会的相互作用やコミュニケーションにおける困難を特徴とします。強迫行為、不適切な社会的相互作用、学習障害、不安、聴覚過敏、反復運動、その他多くの特徴がASDの主な徴候や症状のひとつです。

自閉症スペクトラム障害の有病率の増加と早期診断の需要の増加は、市場の成長を後押しします。例えば、2021年11月、ベングリオン大学の研究者らの研究によると、2.5歳までに自閉症スペクトラム障害と診断されると、診断が遅くなる場合と比較して、社会的症状が劇的に改善することが判明しました。このように、自閉症スペクトラム障害に対する認知度の向上と、自閉症スペクトラム障害の早期診断に対する需要の高まりが、市場の成長を牽引しています。
さらに、自閉症スペクトラム障害の有病率の増加と自閉症スペクトラム障害のサービスに関する意識の高まりは、自閉症スペクトラム障害治療市場の成長を促進する主な要因です。例えば、2022年3月、世界保健機関（WHO）の報告書によると、世界では約100人に1人の子供が自閉症スペクトラム障害であると推定されています。

さらに、自閉症スペクトラム障害に関する意識の高まりや、自閉症スペクトラム障害の診断・サービスを提供する政府・非政府組織の貢献度の上昇が、市場の成長を後押ししています。例えば、ASERT（Autism Services, Education, Resources and Training）は、医療センターや大学からなる組織で、自閉症スペクトラム障害（ASD）を持つ若者の自立を高め、孤立を減らすことを目的としたプログラムであるAutism Awareness, Community Education and Support（AACES）の立ち上げを発表しました。
さらに、先進的な自閉症スペクトラム障害治療の開発のための研究開発活動の増加、疾患の診断の進歩、米国食品医薬品局（USFDA）の承認の増加、主要企業による市場での新規製品の発売が市場の成長を後押ししています。例えば、2021年10月、神経障害や疾患を持つ人々の生活を改善することに専念している臨床段階のバイオ医薬品会社であるAxial Therapeutics社は、自閉症スペクトラム障害に関連する過敏性のサービスのための腸を標的とした分子治療薬であるリード候補、AB-2004の治験新薬（IND）申請の許可を米国食品医薬品局（FDA）から受けました。さらに、自閉症スペクトラムのオンライントレーニングプラットフォームやモバイル疾患など、自閉症スペクトラム治療における進歩は、市場成長にさらに貢献します。しかし、自閉症スペクトラム障害治療の高額な費用や病気に対する認識不足は、市場の成長を妨げる可能性があります。

自閉症スペクトラム障害市場は、サービス、疾患、場所、地域によって区分されます。
サービス別では、市場は行動的アプローチ、早期介入、薬物療法、その他に分類されます。
疾患別では、市場は自閉性障害、アスペルガー症候群、広汎性発達障害（PDD）に分類されます。
場所別では、市場は病院、教育カウンセラーセンター、その他に分類されます。
地域別では、北米、欧州、アジア太平洋、LAMEAに市場を分けて分析しています。

本レポートに掲載されている主要企業には、Abbvie Inc、Axial therapeutics、The Bristol Myers Squibb Company、Cognoa Inc、Curemark LLC、Dfusion Inc、EarliTec Diagnostics Inc、Jaguar Gene Therapy、Jazz Pharmaceuticals、Johnson & Johnson、Neurim Pharmaceuticals Ltd.、Novartis AG、PaxMedica Inc、Pfizer Inc、Stalicla SA、Teva Pharmaceutical Industries Ltd.、Yamo Pharmaceuticals LLCなどがあります。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの自閉症スペクトラム障害市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、優勢な自閉症スペクトラム障害市場機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるようにします。
・自閉症スペクトラム障害市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界の自閉症スペクトラム障害市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
疾患別
自閉性障害
アスペルガー症候群
広汎性発達障害（PDD）
その他

サービス別
行動的アプローチ
早期介入
薬物療法
その他サービス

場所別
病院
教育相談センター
その他

地域別
・北米
アメリカ
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
オーストラリア
インド
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Abbvie Inc
Axial therapeutics
Bristol Myers Squibb Co.
Cognoa Inc
Curemark LLC
dfusion inc.
EarliTec Diagnostics Inc
Jazz Pharmaceuticals
Johnson & Johnson
Novartis AG

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE
4.1 Overview
4.1.1 Market size and forecast
4.2 Autistic Disorder
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Asperger Syndrome
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Pervasive development disorder (PDD)
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Other
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE
5.1 Overview
5.1.1 Market size and forecast
5.2 Behavioural Approaches
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Behavioural Approaches Autism Spectrum Disorders Market by Gender
5.2.4.1 Male Market size and forecast, by region
5.2.4.2 Female Market size and forecast, by region
5.3 Early Intervention
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.3.4 Early Intervention Autism Spectrum Disorders Market by Gender
5.3.4.1 Male Market size and forecast, by region
5.3.4.2 Female Market size and forecast, by region
5.4 Medication
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.4.4 Medication Autism Spectrum Disorders Market by Gender
5.4.4.1 Male Market size and forecast, by region
5.4.4.2 Female Market size and forecast, by region
5.5 Other Services
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.5.4 Other Services Autism Spectrum Disorders Market by Gender
5.5.4.1 Male Market size and forecast, by region
5.5.4.2 Female Market size and forecast, by region
CHAPTER 6: AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Education Counsellor Center
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: AUTISM SPECTRUM DISORDERS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Disease
7.2.3 North America Market size and forecast, by Service
7.2.3.1 North America Behavioural Approaches Autism Spectrum Disorders Market by Gender
7.2.3.2 North America Early Intervention Autism Spectrum Disorders Market by Gender
7.2.3.3 North America Medication Autism Spectrum Disorders Market by Gender
7.2.3.4 North America Other Services Autism Spectrum Disorders Market by Gender
7.2.4 North America Market size and forecast, by Location
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Disease
7.2.5.1.2 Market size and forecast, by Service
7.2.5.1.3 Market size and forecast, by Location
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Disease
7.2.5.2.2 Market size and forecast, by Service
7.2.5.2.3 Market size and forecast, by Location
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Disease
7.2.5.3.2 Market size and forecast, by Service
7.2.5.3.3 Market size and forecast, by Location
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Disease
7.3.3 Europe Market size and forecast, by Service
7.3.3.1 Europe Behavioural Approaches Autism Spectrum Disorders Market by Gender
7.3.3.2 Europe Early Intervention Autism Spectrum Disorders Market by Gender
7.3.3.3 Europe Medication Autism Spectrum Disorders Market by Gender
7.3.3.4 Europe Other Services Autism Spectrum Disorders Market by Gender
7.3.4 Europe Market size and forecast, by Location
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Disease
7.3.5.1.2 Market size and forecast, by Service
7.3.5.1.3 Market size and forecast, by Location
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Disease
7.3.5.2.2 Market size and forecast, by Service
7.3.5.2.3 Market size and forecast, by Location
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Disease
7.3.5.3.2 Market size and forecast, by Service
7.3.5.3.3 Market size and forecast, by Location
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Disease
7.3.5.4.2 Market size and forecast, by Service
7.3.5.4.3 Market size and forecast, by Location
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Disease
7.3.5.5.2 Market size and forecast, by Service
7.3.5.5.3 Market size and forecast, by Location
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Disease
7.3.5.6.2 Market size and forecast, by Service
7.3.5.6.3 Market size and forecast, by Location
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Disease
7.4.3 Asia-Pacific Market size and forecast, by Service
7.4.3.1 Asia-Pacific Behavioural Approaches Autism Spectrum Disorders Market by Gender
7.4.3.2 Asia-Pacific Early Intervention Autism Spectrum Disorders Market by Gender
7.4.3.3 Asia-Pacific Medication Autism Spectrum Disorders Market by Gender
7.4.3.4 Asia-Pacific Other Services Autism Spectrum Disorders Market by Gender
7.4.4 Asia-Pacific Market size and forecast, by Location
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Disease
7.4.5.1.2 Market size and forecast, by Service
7.4.5.1.3 Market size and forecast, by Location
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Disease
7.4.5.2.2 Market size and forecast, by Service
7.4.5.2.3 Market size and forecast, by Location
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Disease
7.4.5.3.2 Market size and forecast, by Service
7.4.5.3.3 Market size and forecast, by Location
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Disease
7.4.5.4.2 Market size and forecast, by Service
7.4.5.4.3 Market size and forecast, by Location
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Disease
7.4.5.5.2 Market size and forecast, by Service
7.4.5.5.3 Market size and forecast, by Location
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Disease
7.5.3 LAMEA Market size and forecast, by Service
7.5.3.1 LAMEA Behavioural Approaches Autism Spectrum Disorders Market by Gender
7.5.3.2 LAMEA Early Intervention Autism Spectrum Disorders Market by Gender
7.5.3.3 LAMEA Medication Autism Spectrum Disorders Market by Gender
7.5.3.4 LAMEA Other Services Autism Spectrum Disorders Market by Gender
7.5.4 LAMEA Market size and forecast, by Location
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Disease
7.5.5.1.2 Market size and forecast, by Service
7.5.5.1.3 Market size and forecast, by Location
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Disease
7.5.5.2.2 Market size and forecast, by Service
7.5.5.2.3 Market size and forecast, by Location
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Disease
7.5.5.3.2 Market size and forecast, by Service
7.5.5.3.3 Market size and forecast, by Location
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Disease
7.5.5.4.2 Market size and forecast, by Service
7.5.5.4.3 Market size and forecast, by Location
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Abbvie Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Axial therapeutics
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Bristol Myers Squibb Co.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cognoa Inc
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Curemark LLC
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 dfusion inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 EarliTec Diagnostics Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Jazz Pharmaceuticals
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Johnson & Johnson
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Novartis AG
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 2. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR AUTISTIC DISORDER, BY REGION, 2021-2031 ($MILLION)
TABLE 3. AUTISM SPECTRUM DISORDERS MARKET FOR AUTISTIC DISORDER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR ASPERGER SYNDROME, BY REGION, 2021-2031 ($MILLION)
TABLE 5. AUTISM SPECTRUM DISORDERS MARKET FOR ASPERGER SYNDROME, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR PERVASIVE DEVELOPMENT DISORDER (PDD), BY REGION, 2021-2031 ($MILLION)
TABLE 7. AUTISM SPECTRUM DISORDERS MARKET FOR PERVASIVE DEVELOPMENT DISORDER (PDD), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR OTHER, BY REGION, 2021-2031 ($MILLION)
TABLE 9. AUTISM SPECTRUM DISORDERS MARKET FOR OTHER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. GLOBAL AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 11. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR BEHAVIOURAL APPROACHES, BY REGION, 2021-2031 ($MILLION)
TABLE 12. AUTISM SPECTRUM DISORDERS MARKET FOR BEHAVIOURAL APPROACHES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. GLOBAL BEHAVIOURAL APPROACHES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 14. AUTISM SPECTRUM DISORDERS MARKET, FOR MALE, BY REGION, 2021-2031 ($MILLION)
TABLE 15. AUTISM SPECTRUM DISORDERS MARKET, FOR FEMALE, BY REGION, 2021-2031 ($MILLION)
TABLE 16. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR EARLY INTERVENTION, BY REGION, 2021-2031 ($MILLION)
TABLE 17. AUTISM SPECTRUM DISORDERS MARKET FOR EARLY INTERVENTION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. GLOBAL EARLY INTERVENTION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 19. AUTISM SPECTRUM DISORDERS MARKET, FOR MALE, BY REGION, 2021-2031 ($MILLION)
TABLE 20. AUTISM SPECTRUM DISORDERS MARKET, FOR FEMALE, BY REGION, 2021-2031 ($MILLION)
TABLE 21. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR MEDICATION, BY REGION, 2021-2031 ($MILLION)
TABLE 22. AUTISM SPECTRUM DISORDERS MARKET FOR MEDICATION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. GLOBAL MEDICATION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 24. AUTISM SPECTRUM DISORDERS MARKET, FOR MALE, BY REGION, 2021-2031 ($MILLION)
TABLE 25. AUTISM SPECTRUM DISORDERS MARKET, FOR FEMALE, BY REGION, 2021-2031 ($MILLION)
TABLE 26. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR OTHER SERVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 27. AUTISM SPECTRUM DISORDERS MARKET FOR OTHER SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. GLOBAL OTHER SERVICES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 29. AUTISM SPECTRUM DISORDERS MARKET, FOR MALE, BY REGION, 2021-2031 ($MILLION)
TABLE 30. AUTISM SPECTRUM DISORDERS MARKET, FOR FEMALE, BY REGION, 2021-2031 ($MILLION)
TABLE 31. GLOBAL AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 32. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 33. AUTISM SPECTRUM DISORDERS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR EDUCATION COUNSELLOR CENTER, BY REGION, 2021-2031 ($MILLION)
TABLE 35. AUTISM SPECTRUM DISORDERS MARKET FOR EDUCATION COUNSELLOR CENTER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 36. AUTISM SPECTRUM DISORDERS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 37. AUTISM SPECTRUM DISORDERS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 38. AUTISM SPECTRUM DISORDERS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 39. NORTH AMERICA AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 40. NORTH AMERICA AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 41. NORTH AMERICA BEHAVIOURAL APPROACHES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 42. NORTH AMERICA EARLY INTERVENTION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 43. NORTH AMERICA MEDICATION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 44. NORTH AMERICA OTHER SERVICES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 45. NORTH AMERICA AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA AUTISM SPECTRUM DISORDERS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 47. U.S. AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 48. U.S. AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 49. U.S. AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 50. CANADA AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 51. CANADA AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 52. CANADA AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 53. MEXICO AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 54. MEXICO AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 55. MEXICO AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 56. EUROPE AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 57. EUROPE AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 58. EUROPE BEHAVIOURAL APPROACHES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 59. EUROPE EARLY INTERVENTION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 60. EUROPE MEDICATION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 61. EUROPE OTHER SERVICES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 62. EUROPE AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 63. EUROPE AUTISM SPECTRUM DISORDERS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. GERMANY AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 65. GERMANY AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 66. GERMANY AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 67. FRANCE AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 68. FRANCE AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 69. FRANCE AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 70. UK AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 71. UK AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 72. UK AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 73. ITALY AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 74. ITALY AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 75. ITALY AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 76. SPAIN AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 77. SPAIN AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 78. SPAIN AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 79. REST OF EUROPE AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 80. REST OF EUROPE AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 81. REST OF EUROPE AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 82. ASIA-PACIFIC AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 83. ASIA-PACIFIC AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 84. ASIA-PACIFIC BEHAVIOURAL APPROACHES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 85. ASIA-PACIFIC EARLY INTERVENTION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 86. ASIA-PACIFIC MEDICATION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 87. ASIA-PACIFIC OTHER SERVICES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 88. ASIA-PACIFIC AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 89. ASIA-PACIFIC AUTISM SPECTRUM DISORDERS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 90. JAPAN AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 91. JAPAN AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 92. JAPAN AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 93. CHINA AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 94. CHINA AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 95. CHINA AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 96. AUSTRALIA AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 97. AUSTRALIA AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 98. AUSTRALIA AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 99. INDIA AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 100. INDIA AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 101. INDIA AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 102. REST OF ASIA-PACIFIC AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 103. REST OF ASIA-PACIFIC AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 104. REST OF ASIA-PACIFIC AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 105. LAMEA AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 106. LAMEA AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 107. LAMEA BEHAVIOURAL APPROACHES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 108. LAMEA EARLY INTERVENTION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 109. LAMEA MEDICATION AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 110. LAMEA OTHER SERVICES AUTISM SPECTRUM DISORDERS MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 111. LAMEA AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 112. LAMEA AUTISM SPECTRUM DISORDERS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 113. BRAZIL AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 114. BRAZIL AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 115. BRAZIL AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 116. SAUDI ARABIA AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 117. SAUDI ARABIA AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 118. SAUDI ARABIA AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 119. SOUTH AFRICA AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 120. SOUTH AFRICA AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 121. SOUTH AFRICA AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 122. REST OF LAMEA AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE, 2021-2031 ($MILLION)
TABLE 123. REST OF LAMEA AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE, 2021-2031 ($MILLION)
TABLE 124. REST OF LAMEA AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION, 2021-2031 ($MILLION)
TABLE 125.ABBVIE INC: COMPANY SNAPSHOT
TABLE 126.ABBVIE INC: OPERATING SEGMENTS
TABLE 127.ABBVIE INC: PRODUCT PORTFOLIO
TABLE 128.ABBVIE INC: NET SALES,
TABLE 129.ABBVIE INC: KEY STRATERGIES
TABLE 130.AXIAL THERAPEUTICS: COMPANY SNAPSHOT
TABLE 131.AXIAL THERAPEUTICS: OPERATING SEGMENTS
TABLE 132.AXIAL THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 133.AXIAL THERAPEUTICS: NET SALES,
TABLE 134.AXIAL THERAPEUTICS: KEY STRATERGIES
TABLE 135.BRISTOL MYERS SQUIBB CO.: COMPANY SNAPSHOT
TABLE 136.BRISTOL MYERS SQUIBB CO.: OPERATING SEGMENTS
TABLE 137.BRISTOL MYERS SQUIBB CO.: PRODUCT PORTFOLIO
TABLE 138.BRISTOL MYERS SQUIBB CO.: NET SALES,
TABLE 139.BRISTOL MYERS SQUIBB CO.: KEY STRATERGIES
TABLE 140.COGNOA INC: COMPANY SNAPSHOT
TABLE 141.COGNOA INC: OPERATING SEGMENTS
TABLE 142.COGNOA INC: PRODUCT PORTFOLIO
TABLE 143.COGNOA INC: NET SALES,
TABLE 144.COGNOA INC: KEY STRATERGIES
TABLE 145.CUREMARK LLC: COMPANY SNAPSHOT
TABLE 146.CUREMARK LLC: OPERATING SEGMENTS
TABLE 147.CUREMARK LLC: PRODUCT PORTFOLIO
TABLE 148.CUREMARK LLC: NET SALES,
TABLE 149.CUREMARK LLC: KEY STRATERGIES
TABLE 150.DFUSION INC.: COMPANY SNAPSHOT
TABLE 151.DFUSION INC.: OPERATING SEGMENTS
TABLE 152.DFUSION INC.: PRODUCT PORTFOLIO
TABLE 153.DFUSION INC.: NET SALES,
TABLE 154.DFUSION INC.: KEY STRATERGIES
TABLE 155.EARLITEC DIAGNOSTICS INC: COMPANY SNAPSHOT
TABLE 156.EARLITEC DIAGNOSTICS INC: OPERATING SEGMENTS
TABLE 157.EARLITEC DIAGNOSTICS INC: PRODUCT PORTFOLIO
TABLE 158.EARLITEC DIAGNOSTICS INC: NET SALES,
TABLE 159.EARLITEC DIAGNOSTICS INC: KEY STRATERGIES
TABLE 160.JAZZ PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 161.JAZZ PHARMACEUTICALS: OPERATING SEGMENTS
TABLE 162.JAZZ PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 163.JAZZ PHARMACEUTICALS: NET SALES,
TABLE 164.JAZZ PHARMACEUTICALS: KEY STRATERGIES
TABLE 165.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 166.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 167.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 168.JOHNSON & JOHNSON: NET SALES,
TABLE 169.JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 170.NOVARTIS AG: COMPANY SNAPSHOT
TABLE 171.NOVARTIS AG: OPERATING SEGMENTS
TABLE 172.NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 173.NOVARTIS AG: NET SALES,
TABLE 174.NOVARTIS AG: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • メンタルヘルスのグローバル市場（2020～2030）：アルコール使用障害、薬物乱用障害、摂食障害、ADHD、その他
  • アクションフィギュア玩具のグローバル市場（2020～2030）：プラスチック素材、シリコン素材、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23JN081 )"自閉症スペクトラム障害のグローバル市場（2020～2030）：自閉症、アスペルガー症候群、広汎性発達障害（PDD）、その他" (英文：Autism Spectrum Disorders Market By Disease (Autistic Disorder, Asperger Syndrome, Pervasive development disorder (PDD), Other), By Service (Behavioural Approaches, Early Intervention, Medication, Other Services), By Location (Hospitals, Education Counsellor Center, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。